237 related articles for article (PubMed ID: 12841368)
1. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C.
Vankova J; Stepanova I; Jech R; Elleder M; Ling L; Mignot E; Nishino S; Nevsimalova S
Sleep; 2003 Jun; 26(4):427-30. PubMed ID: 12841368
[TBL] [Abstract][Full Text] [Related]
2. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
[TBL] [Abstract][Full Text] [Related]
3. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
5. Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.
Andlauer O; Moore H; Jouhier L; Drake C; Peppard PE; Han F; Hong SC; Poli F; Plazzi G; O'Hara R; Haffen E; Roth T; Young T; Mignot E
JAMA Neurol; 2013 Jul; 70(7):891-902. PubMed ID: 23649748
[TBL] [Abstract][Full Text] [Related]
6. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
[TBL] [Abstract][Full Text] [Related]
7. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
[TBL] [Abstract][Full Text] [Related]
8. Niemann-Pick disease type C: cataplexy and hypocretin in cerebrospinal fluid.
Oyama K; Takahashi T; Shoji Y; Oyamada M; Noguchi A; Tamura H; Takada G; Kanbayashi T
Tohoku J Exp Med; 2006 Jul; 209(3):263-7. PubMed ID: 16778374
[TBL] [Abstract][Full Text] [Related]
9. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexy.
Jeong JH; Hong SC; Shin YK; Han JH; Lee SP
J Korean Med Sci; 2007 Feb; 22(1):127-31. PubMed ID: 17297265
[TBL] [Abstract][Full Text] [Related]
11. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
[TBL] [Abstract][Full Text] [Related]
12. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S
Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400
[TBL] [Abstract][Full Text] [Related]
13. Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.
Kubota H; Kanbayashi T; Tanabe Y; Ito M; Takanashi J; Kohno Y; Shimizu T
Sleep; 2003 Aug; 26(5):555-7. PubMed ID: 12938807
[TBL] [Abstract][Full Text] [Related]
14. [Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia].
Martínez-Rodríguez JE; Iranzo A; Casamitjana R; Graus F; Santamaria J
Med Clin (Barc); 2007 Mar; 128(10):361-4. PubMed ID: 17386240
[TBL] [Abstract][Full Text] [Related]
15. [Narcolepsy-cataplexy].
Deflandre E; Roelants F; Cambron L; Poirrier R
Rev Med Liege; 2002 Aug; 57(8):519-27. PubMed ID: 12405025
[TBL] [Abstract][Full Text] [Related]
16. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
Knudsen S; Gammeltoft S; Jennum PJ
Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
[TBL] [Abstract][Full Text] [Related]
17. Hypocretin deficiency in niemann-pick type C with cataplexy.
Kanbayashi T; Abe M; Fujimoto S; Miyachi T; Takahashi T; Yano T; Sawaishi Y; Arii J; Szilagyi G; Shimizu T
Neuropediatrics; 2003 Feb; 34(1):52-3. PubMed ID: 12690569
[No Abstract] [Full Text] [Related]
18. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
19. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
Khatami R; Maret S; Werth E; Rétey J; Schmid D; Maly F; Tafti M; Bassetti CL
Lancet; 2004 Apr; 363(9416):1199-200. PubMed ID: 15081654
[TBL] [Abstract][Full Text] [Related]
20. A series of 7 cases of patients with narcolepsy with hypocretin deficiency without the HLA DQB1*06:02 allele.
Miano S; Barateau L; De Pieri M; Riccardi S; Thevenin C; Manconi M; Dauvilliers Y
J Clin Sleep Med; 2023 Dec; 19(12):2053-2057. PubMed ID: 37539640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
